1 reports of this reaction
6.3% of all FERRUM PHOSPHORICUM reports
#5 most reported adverse reaction
ECZEMA is the #5 most commonly reported adverse reaction for FERRUM PHOSPHORICUM, manufactured by Energique, Inc.. There are 1 FDA adverse event reports linking FERRUM PHOSPHORICUM to ECZEMA. This represents approximately 6.3% of all 16 adverse event reports for this drug.
Patients taking FERRUM PHOSPHORICUM who experience eczema should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ECZEMA is moderately reported among FERRUM PHOSPHORICUM users, representing a notable but not dominant share of adverse events.
In addition to eczema, the following adverse reactions have been reported for FERRUM PHOSPHORICUM:
The following drugs have also been linked to eczema in FDA adverse event reports:
ECZEMA has been reported as an adverse event in 1 FDA reports for FERRUM PHOSPHORICUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
ECZEMA accounts for approximately 6.3% of all adverse event reports for FERRUM PHOSPHORICUM, making it a notable side effect.
If you experience eczema while taking FERRUM PHOSPHORICUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.